Hepatitis E Virus (HEV) is a non-enveloped, icosahedral virus with a single-stranded positive-sense RNA genome. HEV mainly targets hepatocytes. After entering the body through the oral-fecal route, HEV replicates in the liver. HEV has four genotypes (HEV-1, HEV-2, HEV-3, and HEV-4). HEV-1 and HEV-2 are human-specific genotypes, while HEV-3 and HEV-4 are zoonotic genotypes. In acute infections, HEV can cause symptoms such as jaundice, fever, and abdominal pain. In some cases, especially in pregnant women and immunosuppressed individuals, the infection can be severe and lead to fulminant liver failure or chronic hepatitis[1][2].
Antiviral agent 77 (Compound 46) 是一种强效、口服有效且可透过血脑屏障的抗病毒剂,对 CedV(在 rCedV-Luc 报告基因检测中 EC50:1.08 μM)、NiV-M(EC50:2.91 μM)、NiV-B 和 HeV 均显示出抗病毒活性。
SCR005 是一种具有广谱抗病毒活性的合成碳水化合物受体 (SCR),可抑制多种病毒家族的包膜病毒进入(冠状病毒科:SARS-CoV-1、SARS-CoV-2、MERS-CoV;丝状病毒科:EBOV、MARV;副黏病毒科:NiV、HeV)以及糖基化的非包膜轮状病毒,其通过结合病毒包膜 N-糖基来阻断病毒与宿主细胞的结合或同时阻断结合和膜融合,并在感染 SARS-CoV-2 的 hACE2 小鼠中发挥预防作用,可用于包膜病毒大流行的研究和预防。
© 2026 MolStrong. 保留所有权利。粤ICP备2023004355号
可通过CAS号进行批量搜索,一行一个CAS号